已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Aramchol improves hepatic fibrosis in metabolic dysfunction–associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology

纤维化 医学 内科学 脂肪性肝炎 胃肠病学 肝病学 病理 脂肪肝 疾病
作者
Vlad Ratziu,Yusuf Yılmaz,Don Lazas,Scott L. Friedman,C. Lackner,Cynthia Behling,Oscar W. Cummings,Li Chen,Mathieu Petitjean,Yossi Gilgun‐Sherki,Tali Gorfine,Shaul Kadosh,Eli Eyal,Arun J. Sanyal
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
被引量:5
标识
DOI:10.1097/hep.0000000000000980
摘要

Background and Aims: Antifibrotic trials rely on conventional pathology despite recognized limitations. We compared single-fiber digital image analysis with conventional pathology to quantify the antifibrotic effect of Aramchol, a stearoyl-CoA desaturase 1 inhibitor in development for metabolic dysfunction–associated steatohepatitis. Approach and Results: Fifty-one patients with metabolic dysfunction–associated steatohepatitis enrolled in the open-label part of the ARMOR trial received Aramchol 300 mg BID and had paired pre-post treatment liver biopsies scored by consensus among 3 hepatopathologists, and separately assessed by a digital image analysis platform (PharmaNest) that generates a continuous phenotypic Fibrosis Composite Severity (Ph-FCS) score. Fibrosis improvement was defined as: ≥1 NASH Clinical Research Network (NASH-CRN) stage reduction; “improved” by ranked pair assessment; reduction in Ph-FCS (“any” for ≥0.3 absolute reduction and “substantial” for ≥25% relative reduction). Fibrosis improved in 31% of patients (NASH-CRN), 51% (ranked pair assessment), 74.5% (any Ph-FCS reduction), and 41% (substantial Ph-FCS reduction). Most patients with stable fibrosis by NASH-CRN or ranked pair assessment had a Ph-FCS reduction (a third with substantial reduction). Fibrosis improvement increased with treatment duration: 25% for <48 weeks versus 39% for ≥48 weeks by NASH-CRN; 43% versus 61% by ranked pair assessment, mean Ph-FCS reduction −0.54 (SD: 1.22) versus −1.72 (SD: 1.02); Ph-FCS reduction (any in 54% vs. 100%, substantial in 21% vs. 65%). The antifibrotic effect of Aramchol was corroborated by reductions in liver stiffness, Pro-C3, and enhanced liver fibrosis. Changes in Ph-FCS were positively correlated with changes in liver stiffness. Conclusions: Continuous fibrosis scores generated in antifibrotic trials by digital image analysis quantify antifibrotic effects with greater sensitivity and a larger dynamic range than conventional pathology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wangfaqing942完成签到 ,获得积分10
1秒前
短巷完成签到 ,获得积分10
1秒前
PAIDAXXXX完成签到,获得积分10
2秒前
平常安雁完成签到 ,获得积分10
8秒前
9秒前
16秒前
可爱的函函应助芯之痕采纳,获得10
19秒前
numagok完成签到,获得积分10
19秒前
李治稳发布了新的文献求助10
23秒前
23秒前
养乐多敬你完成签到 ,获得积分10
28秒前
缓慢新梅完成签到,获得积分10
32秒前
万能图书馆应助缓慢新梅采纳,获得10
37秒前
40秒前
WillGUO发布了新的文献求助10
44秒前
科研通AI2S应助稳重筝采纳,获得10
50秒前
bkagyin应助zhangzhi采纳,获得10
52秒前
52秒前
梦醒了完成签到 ,获得积分10
56秒前
57秒前
西吴完成签到 ,获得积分10
57秒前
李爱国应助Guesss采纳,获得10
59秒前
59秒前
小呵点完成签到 ,获得积分10
1分钟前
打打应助周多多采纳,获得10
1分钟前
芯之痕发布了新的文献求助10
1分钟前
leigod完成签到 ,获得积分10
1分钟前
心系天下完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
zhoutiantian完成签到 ,获得积分10
1分钟前
埃特纳氏完成签到 ,获得积分10
1分钟前
冉冉爱吃西瓜完成签到,获得积分10
1分钟前
在水一方应助nature采纳,获得10
1分钟前
神勇语堂完成签到 ,获得积分10
1分钟前
1分钟前
酷波er应助aa采纳,获得10
1分钟前
李健应助薄红采纳,获得10
1分钟前
明水完成签到,获得积分10
1分钟前
彩色的紫丝完成签到 ,获得积分10
1分钟前
筱筱完成签到 ,获得积分10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976600
求助须知:如何正确求助?哪些是违规求助? 3520674
关于积分的说明 11204470
捐赠科研通 3257316
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877861
科研通“疑难数据库(出版商)”最低求助积分说明 806595